Q4 2018 13F Holders as of 12/31/2018
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
84.7M
-
Number of holders
-
41
-
Total 13F shares, excl. options
-
9.71M
-
Shares change
-
-74.3K
-
Total reported value, excl. options
-
$87.2M
-
Value change
-
-$2.78M
-
Number of buys
-
28
-
Number of sells
-
-17
-
Price
-
$9.02
Significant Holders of SUTRO BIOPHARMA, INC. - Common Stock, par value $0.001 per share (STRO) as of Q4 2018
51 filings reported holding STRO - SUTRO BIOPHARMA, INC. - Common Stock, par value $0.001 per share as of Q4 2018.
SUTRO BIOPHARMA, INC. - Common Stock, par value $0.001 per share (STRO) has 41 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9.71M shares
of 84.7M outstanding shares and own 11.46% of the company stock.
Largest 10 shareholders include SV Health Investors, LLC (1.82M shares), CITADEL ADVISORS LLC (1.73M shares), EVENTIDE ASSET MANAGEMENT, LLC (1.24M shares), Samsara BioCapital, LLC (1.13M shares), Camber Capital Management LP (600K shares), BlackRock Inc. (410K shares), SPHERA FUNDS MANAGEMENT LTD. (408K shares), FMR LLC (400K shares), DRIEHAUS CAPITAL MANAGEMENT LLC (330K shares), and Sio Capital Management, LLC (282K shares).
This table shows the top 41 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.